Share

In the January Journal Club, we discussed the new drug J147 which targets mitochondrial dysfunction to potentially treat Alzheimer’s and other age-related diseases. We have also discussed the topic in an article last week if you wish to read about the progress being made with this drug.

Reference

Goldberg, J., Currais, A., Prior, M., Fischer, W., Chiruta, C., Ratliff, E., … & Cuezva, J. M. (2018). The mitochondrial ATP synthase is a shared drug target for aging and dementia. Aging cell.

Write a comment:

*

Your email address will not be published.

7 + 3 =

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD